To assess the extent and adequacy of pre-operative sexual function (SF) counseling in females undergoing radical cystectomy (RC) and develop educational material to improve identified deficits. A 10-question survey was electronically delivered to all females who underwent RC at a single institution between 2015 and 2020.
The standard of care for nonmuscle invasive bladder cancer (NMIBC) is the transurethral resection of bladder tumor (TURBT), followed by a risk-adapted approach involving adjuvant intravesical chemotherapy or immunotherapy (IO) to reduce both tumor recurrence and progression rates.1 Particularly, for intermediate- and high-risk NMIBC, Bacillus Calmette-Guerin (BCG) is the standard adjuvant treatment. However, a non-negligible portion […]
COVID 19 is a pandemic never seen by mankind before. The infection has changed the priority and management of various urologic diseases. Today, deferring of treatments is being discussed, mainly in uro-oncology diseases.
Clinical management of testicular germ cell tumours (GCTs) is hampered by low sensitivity and specificity of the biomarkers currently in use. Circulating microRNAs (miRs) might offer the potential to address areas of unmet clinical need.
To investigate the diagnostic performance of a deep convolutional neural network for differentiation of clear cell renal cell carcinoma (ccRCC) from renal oncocytoma. In this retrospective study, 74 patients (49 male, mean age 59.
Pancreatic metastases (PM) are rare in renal cell carcinoma. It has been suggested that patients with metastases to the pancreas have a more favorable prognosis, but little is known about the long-term outcomes with systemic therapy.
Treatment selection for localized prostate cancer is guided by risk stratification and patient preferences. While socioeconomic status (SES) disparities exist for access to care, less is known on the effect of SES on treatment decision making.
This study aimed to investigate if preoperative assessments of multiparametric magnetic resonance imaging (mpMRI) and Magnetic resonance imaging /ultrasound (MRI/US) fusion-guided prostate biopsy could be used to guide focal therapy for prostate cancer.
The optimal definition and prognostic significance of persistently elevated prostate-specific antigen (PSA) after salvage lymph node dissection (sLND) for node-only recurrent prostate cancer (PCa) remain unknown.
To evaluate whether bilateral prostate cancer detected at Active Surveillance (AS) enrollment is associated with progression to Grade Group ≥2 (GG2) and to compare the efficacy of combined targeted biopsy plus systematic biopsy (CBx) versus systematic biopsy (Sbx) or targeted biopsy (Tbx) alone to detect bilateral disease.
